AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Sees Large Increase in Short Interest

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) saw a large growth in short interest in December. As of December 31st, there was short interest totaling 7,848 shares, a growth of 321.3% from the December 15th total of 1,863 shares. Based on an average trading volume of 1,541,052 shares, the days-to-cover ratio is currently 0.0 days. Based on an average trading volume of 1,541,052 shares, the days-to-cover ratio is currently 0.0 days.

AXIM Biotechnologies Stock Down 6.3%

AXIM Biotechnologies stock opened at $0.01 on Thursday. AXIM Biotechnologies has a 1-year low of $0.00 and a 1-year high of $0.03. The company has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.01.

About AXIM Biotechnologies

AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.

The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.